Less Ads, More Data, More Tools Register for FREE

Pin to quick picksChrysalis Inves Regulatory News (CHRY)

Share Price Information for Chrysalis Inves (CHRY)

Share Price is delayed by 15 minutes
Get Live Data
77.30    0.60 (0.78%)
Bid:
77.30
Ask:
77.50
Spread: 0.20 (0.259%)
Market Cap: £371.79m
CHRY Live PriceLast checked at - London Stock Exchange

Intraday Chrysalis Inves Share Chart

Portfolio Update

1 Jun 2021 14:38

RNS Number : 4641A
Chrysalis Investments Limited
01 June 2021
 

The information contained in this announcement is restricted and is not for publication, release or distribution in the United States of America, any member state of the European Economic Area, Canada, Australia, Japan or the Republic of South Africa.

 

 

1 June 2021

 

 

Chrysalis Investments Limited ("Chrysalis" or the "Company")

 

Portfolio Update

 

The Company is pleased to announce that FinanceApp AG (''wefox''), the Berlin-based digital insurance company, has successfully raised $650m for its Series C funding round resulting in a post-money valuation of US$3 billion.

wefox is Europe's leading digital insurance company and the round is the largest for an 'insurtech' business globally and one of the largest Series C rounds ever recorded. wefox intends to invest the proceeds in strengthening its presence in existing markets and expanding globally within the next two years.

The funding round was significantly oversubscribed with strong participation from existing investors as well as new investors such as LGT, Partners Group, EDBI and Lightrock. The Company participated in the funding round with an investment of 30m. This takes the Company's total investment in wefox to date to 74.4m.

Prior to this funding round, the Company had completed four investments into wefox via a series of convertible loans. These four separate investments totalled 44.4m. The current valuation represents a 2.2x return on those four investments and an IRR of 157%.

Due to visibility over the funding round, the reported valuation has already been captured in the Company's reported 31 March NAV.

The Company's convertible loan notes have now converted to equity as a result of this transaction.

 

Nick Williamson and Richard Watts (co-portfolio managers) comment:

"We would like to congratulate the team at wefox on their successful fundraise. wefox has been an extremely successful investment for Chrysalis and demonstrates our ability to identify attractive opportunities across Europe.

We have now completed five investments in the company, and this is further evidence of Chrysalis utilising its scale to drive successful outcomes and extraordinary returns for its shareholders. We look forward to supporting wefox through its ambitious plans for 2021 and beyond."

 

-ENDS-

 

 

 

 

 

 

 

 

 

For further information, please contact:

 

Media:

Montfort Communications

Charlotte McMullen, Toto Reissland-Burghart, Miles McKechnie

 

 

 

Chrysalis@montfort.london

+44 (0) 20 3770 7920

Jupiter Asset Management:

Magnus Spence

 

+44 (0) 20 3817 1325

Liberum:

Chris Clarke / Darren Vickers / Owen Matthews

 

+44 (0) 20 3100 2000

Numis:

Nathan Brown / Matt Goss

 

+44 (0) 20 7260 1000

Maitland Administration (Guernsey) Limited:

Elaine Smeja / Aimee Gontier

+44 (0) 1481 749364

 

LEI: 213800F9SQ753JQHSW24

A copy of this announcement will be available on the Company's website at https://www.chrysalisinvestments.co.uk 

The information contained in this announcement regarding the Company's investments has been provided by the relevant underlying portfolio company and has not been independently verified by the Company. The information contained herein is unaudited.

This announcement is for information purposes only and is not an offer to invest. All investments are subject to risk. Past performance is no guarantee of future returns. Prospective investors are advised to seek expert legal, financial, tax and other professional advice before making any investment decision. The value of investments may fluctuate. Results achieved in the past are no guarantee of future results.

Neither the content of the Company's website, nor the content on any website accessible from hyperlinks on its website for any other website, is incorporated into, or forms part of, this announcement nor, unless previously published by means of a recognised information service, should any such content be relied upon in reaching a decision as to whether or not to acquire, continue to hold, or dispose of, securities in the Company.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PFUFLFVVRRILIIL
Date   Source Headline
18th May 20264:11 pmRNSDirector/PDMR Shareholding
12th May 202610:11 amRNSDirector/PDMR Shareholding
7th May 202611:38 amRNSDirector/PDMR Shareholding
5th May 20267:44 amRNSQuarterly NAV Announcement and Trading Update
5th May 20267:01 amRNSManagement Arrangements and Self-Managed Model
1st May 20267:00 amRNSTransaction in Own Shares
30th Apr 20267:00 amRNSTransaction in Own Shares
29th Apr 20267:00 amRNSTransaction in Own Shares
28th Apr 20267:00 amRNSTransaction in Own Shares
27th Apr 20267:00 amRNSTransaction in Own Shares
24th Apr 20267:00 amRNSTransaction in Own Shares
23rd Apr 20267:00 amRNSTransaction in Own Shares
22nd Apr 20267:00 amRNSTransaction in Own Shares
21st Apr 20267:00 amRNSTransaction in Own Shares
20th Apr 20267:00 amRNSTransaction in Own Shares
17th Apr 20267:00 amRNSTransaction in Own Shares
16th Apr 20267:00 amRNSTransaction in Own Shares
15th Apr 20267:00 amRNSTransaction in Own Shares
14th Apr 20267:00 amRNSTransaction in Own Shares
13th Apr 20267:00 amRNSTransaction in Own Shares
10th Apr 20267:00 amRNSTransaction in Own Shares
8th Apr 20267:00 amRNSTransaction in Own Shares
7th Apr 20267:00 amRNSTransaction in Own Shares
2nd Apr 20267:00 amRNSTransaction in Own Shares
1st Apr 20267:00 amRNSTransaction in Own Shares
31st Mar 20264:01 pmRNSResult of AGM
31st Mar 20263:26 pmRNSResults of AGM
31st Mar 20267:00 amRNSTransaction in Own Shares
30th Mar 20267:00 amRNSTransaction in Own Shares
26th Mar 20267:00 amRNSTransaction in Own Shares
25th Mar 20267:00 amRNSTransaction in Own Shares
24th Mar 20264:24 pmRNSResults of EGM
24th Mar 20267:00 amRNSTransaction in Own Shares
23rd Mar 20267:00 amRNSTransaction in Own Shares
20th Mar 20267:00 amRNSTransaction in Own Shares
19th Mar 20269:50 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20269:59 amRNSTransaction in Own Shares
13th Mar 20269:59 amRNSTransaction in Own Shares
12th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20264:21 pmRNSNotice of AGM
10th Mar 20264:21 pmRNSNotice of AGM
10th Mar 20267:01 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSLiquidity and Cash Update
9th Mar 20267:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.